Due to an increasing trend of HIV drug resistance (HIVDR) to non-nucleoside reverse-transcriptase inhibitor (NNRTI), nucleoside reverse transcriptase inhibitor (NRTI), and protease inhibitors (PI), integrase strand transfer inhibitor (INSTI)-based regimens are now recommended as first-line combination ART in several updated treatment guidelines 4 .
← all excerpts
Low level of HIV-1C integrase strand transfer inhibitor resistance mutations among recently diagnosed ART-naive Ethiopians.
1
—
—